European Pharmaceutical Review

JULY 20, 2022

Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. 1 But while data on adverse reactions is rightly used to help with these decisions, there is currently no additional modelling on the positive impact regulatory action could have on public health. Study focus.

Adverse Reactions 97

Adverse Reactions Diabetes Hospitals Drug Development 97

European Pharmaceutical Review

JUNE 2, 2023

The new Intracellular Drug Delivery Centre CPI’s Intracellular Drug Delivery Centre will help predict the stability, efficacy, performance and any potential adverse reactions of RNA vaccines and therapeutics. Novel drug delivery systems like LNPs are needed for RNA therapeutic developments.

Adverse Reactions 105

Adverse Reactions Vaccines Drug Development 105

BioPharma Dive

JUNE 30, 2025

Published June 30, 2025 Jonathan Gardner Senior Reporter post share post print email license Moderna announced results from an influenza vaccine clinical trial on June 30, 2025. FDA submission of the flu vaccine data could also pave the way for Moderna to also seek approval of a combination COVID-19 and influenza shot.

Vaccines 40

Vaccines Adverse Reactions Drug Pricing Pharmaceutical Companies 40